• Cefepime (BMY-28142) in Resistance-Aware Assays

  2026-08-31

  Cefepime (BMY-28142) offers a research framework for connecting broad-spectrum antibacterial activity, CNS exposure, and resistance phenotyping. This article explains how time-resolved assays and adaptive-resistance modeling can improve bacterial infection model design.

• Hepatocyte Arrb2 and 6-ketoLCA in Liver IRI

  2026-08-30

  This study identifies hepatocyte β-arrestin 2, encoded by Arrb2, as an immunometabolic regulator of hepatic ischemia–reperfusion injury. By connecting hepatocyte Arrb2 with increased 6-ketoLCA and M2 macrophage polarization, the work provides a mechanistic framework for studying liver injury resolution and transplantation outcomes.

• KN-62 for CaMKII and Calcium Signaling Workflows

  2026-08-29

  KN-62 provides a selective way to test whether CaMKII links calcium signals to secretion, glucose handling, or cell-cycle behavior. This practical guide combines dose planning, orthogonal calcium assays, and troubleshooting to separate kinase-dependent effects from upstream channel pharmacology.

• CHI3L1-IN-5: A Translational Route to Astrocyte Repair

  2026-08-29

  CHI3L1-IN-5, also known as Compound Z17, connects selective CHI3L1 inhibition with CNS exposure, NF-κB pathway modulation, astrocyte Aβ uptake restoration, and lysosomal function repair. This thought-leadership guide places the compound in a translational framework while distinguishing product-specific evidence from broader medicinal-chemistry lessons.

• Central Control of Opioid Mechanical Hypersensitivity

  2026-08-28

  Yin et al. identify a brain-to-spinal opioid pathway linking lateral parabrachial MOR neurons, hypothalamic dynorphin neurons, and spinal KOR-expressing GABAergic neurons to morphine-induced mechanical hypersensitivity and tolerance. The study shows that local MOR activation can paradoxically worsen mechanical pain and that circuit-level interventions can rescue these effects in mice, providing a framework for more precise pain mechanism research.

• Sorafenib Workflows for Antiangiogenic Cancer Research

  2026-08-28

  Build more informative cancer assays with Sorafenib (BAY-43-9006) by pairing tumor proliferation measurements with RAF/MEK/ERK signaling and endothelial tube-formation readouts. This workflow positions the compound as a practical cancer biology research tool for distinguishing direct cytotoxicity from VEGFR-driven antiangiogenic effects.

• MRSA Extracellular Vesicles Drive OSCC via IL-8

  2026-08-27

  A 2026 Journal of Advanced Research study shows that extracellular vesicles released by methicillin-resistant Staphylococcus aureus can promote oral squamous cell carcinoma growth through an IL-8–CXCR1 signaling relay. By comparing MRSA and MSSA vesicles with pathway inhibition, genetic validation, and mouse tumor experiments, the work identifies antibiotic-resistant bacterial vesicles as active regulators of tumor biology rather than passive infection byproducts.

• Y-27632 (B1293): Practical ROCK Inhibitor Workflow

  2026-08-27

  Y-27632 (SKU B1293) provides reversible, ATP-competitive inhibition of ROCK1 and ROCK2 for controlled studies of cytoskeletal dynamics, stress fibers, and ROCK signaling. It is intended for in vitro and cellular research only; the guidance below is dossier-based and should not be interpreted as clinical, diagnostic, or disease-treatment evidence.

• Z-VEID-FMK: Reliable Caspase-6 Assays

  2026-08-26

  Learn how Z-VEID-FMK (SKU A1923) can clarify caspase-6-dependent apoptosis in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay design, solvent compatibility, protocol optimization, data interpretation, and practical product selection.

• Targeted EPO mRNA Nanoparticles for Spinal Cord Injury

  2026-08-26

  A 2026 study developed mannose-modified lipid nanoparticles to deliver EPO mRNA to CD206-enriched inflammatory macrophages and microglia after spinal cord injury. In mice, localized EPO expression reduced neuroinflammation and ferroptosis-associated damage while preserving neural structures and improving motor recovery, supporting a targeted mRNA strategy rather than systemic EPO administration.

• Vidarabine Monohydrate: Workflow for Antiviral Research

  2026-08-25

  Build more reproducible antiviral experiments with a DMSO-compatible nucleoside analog designed for mechanistic studies of viral DNA synthesis. This guide connects stock preparation, infection-model design, orthogonal readouts, and troubleshooting for herpes simplex virus research and broader DNA-virus workflows.

• Nocodazole as a Reversible Cell-State Probe

  2026-08-25

  Nocodazole is a reversible microtubule polymerization inhibitor that can do more than arrest mitosis. This article explains how to use it as a temporally controlled cell-state probe while interpreting microtubule, trafficking, and genome-maintenance assays without conflating distinct mechanisms.

• Mdivi-1 Workflows for Mitochondrial Dynamics

  2026-08-24

  Mdivi-1 provides a practical chemical approach for testing whether DRP1-dependent fission contributes to mitochondrial remodeling, apoptosis, or retinal injury. This workflow connects live-cell morphology with apoptosis assay, mitochondrial outer membrane permeabilization, and ECM-to-mitochondria signaling while emphasizing dose control and orthogonal validation.

• LNP Self-Replicating RNA Vaccine Storage

  2026-08-23

  Kim and colleagues systematically evaluated how temperature, buffer composition, sucrose, and lyophilization affect lipid nanoparticle-formulated self-replicating RNA vaccines. Their results identify RNase-free PBS with 10% sucrose at −20 °C as a practical 30-day storage condition that preserved structural integrity and in vivo potency, while also supporting lyophilization as a potential alternative.

• I-BET-762 Workflows for BET Inhibition

  2026-08-22

  I-BET-762 combines nanomolar BET-family potency with practical workflows for inflammatory signaling, transcriptional regulation, and ferroptosis research. This guide translates reference-study findings into assay design, combination screens, and troubleshooting strategies for preclinical models.

449 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page